Dube Eric M
CIK 1763494
Transactions on file
34
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-19 | 2026-10-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 78,400 | $4.31M | -9.0% | open → |
| 2026-10-19 | 2026-10-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 37,270 | $2.02M | -7.6% | open → |
| 2026-10-19 | 2026-10-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 128,065 | $6.78M | -5.5% | open → |
| 2026-10-19 | 2026-10-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 200,000 | $1.79M | +460.8% | open → |
| 2026-10-19 | 2026-10-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 43,735 | $1.18M | +86.3% | open → |
| 2026-09-18 | 2026-09-17 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 6,802 | $441.8K | -22.9% | open → |
| 2026-09-18 | 2026-09-17 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 101,691 | $6.57M | -22.5% | open → |
| 2026-09-18 | 2026-09-17 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 108,493 | $2.53M | +114.6% | open → |
| 2026-09-18 | 2026-09-16 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 96,125 | $6.12M | -21.3% | open → |
| 2026-09-18 | 2026-09-16 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 99,716 | $6.31M | -20.8% | open → |
| 2026-09-18 | 2026-09-16 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 195,841 | $4.57M | +114.6% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 270 | $17.6K | -23.3% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 3,102 | $197.4K | -21.3% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 28,796 | $1.80M | -20.1% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 63,498 | $3.94M | -19.2% | open → |
| 2026-09-18 | 2026-09-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 95,666 | $2.23M | +114.6% | open → |
| 2026-04-15 | 2026-04-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 20 | $853.20 | +17.4% | open → |
| 2026-04-15 | 2026-04-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 7,165 | $299.1K | +20.0% | open → |
| 2026-04-15 | 2026-04-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 56,815 | $2.33M | +22.1% | open → |
| 2026-04-15 | 2026-04-13 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Grant | 64,000 | $0.00 | — | open → |
| 2025-01-23 | 2025-01-22 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Sale | 10,736 | $208.9K | +157.3% | open → |
| 2025-02-04 | 2025-01-31 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Grant | 130,000 | $0.00 | — | open → |
| 2025-02-04 | 2025-02-03 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Sale | 50,691 | $1.02M | +147.8% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Sale | 11,375 | $273.5K | +108.3% | open → |
| 2025-05-05 | 2025-05-05 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Sale | 18,924 | $398.4K | +137.9% | open → |
| 2025-05-05 | 2025-05-02 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Exer. | 18,924 | — | — | open → |
| 2026-05-07 | 2026-05-06 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 22,500 | $988.9K | +13.9% | open → |
| 2026-05-07 | 2026-05-04 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 22,500 | $0.00 | — | open → |
| 2026-02-24 | 2026-02-20 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 60,000 | $1.81M | +66.4% | open → |
| 2026-02-24 | 2026-02-20 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 60,000 | $927.6K | +223.9% | open → |
| 2025-10-30 | 2025-10-29 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 27,128 | $817.1K | +66.3% | open → |
| 2025-10-30 | 2025-10-29 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 27,128 | $419.4K | +223.9% | open → |
| 2025-10-30 | 2025-10-28 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 92,872 | $2.82M | +64.9% | open → |
| 2025-10-30 | 2025-10-28 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 92,872 | $1.44M | +223.9% | open → |
